AN2 THERAPEUTICS INC (ANTX) Institutional Ownership Changes & 13F Activity
AN2 THERAPEUTICS INC (ANTX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Citadel Advisors Llc, Commodore Capital Lp, Summittx Capital, L.P., Balyasny Asset Management L.P., and Ameriprise Financial Inc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| State Street Corp | Buy | +196,400 | +170.5% | 311,602 | $1.51M | Q2 2026 | Sep 22, 2026 |
| Citadel Advisors Llc | Buy | +796,758 | +513.2% | 951,997 | $4.61M | Q2 2026 | Sep 02, 2026 |
| Stonepine Capital Management, Llc | Sell | -162,153 | -22.7% | 551,692 | $2.67M | Q2 2026 | Aug 17, 2026 |
| Almitas Capital Llc | Sell | -10,000 | -0.7% | 1,469,129 | $7.11M | Q2 2026 | Aug 17, 2026 |
| Seven Fleet Capital Management Lp | Buy | +9,245 | +4.6% | 208,946 | $1.01M | Q2 2026 | Aug 17, 2026 |
| Commodore Capital Lp | Buy | +599,967 | +25.7% | 2,933,680 | $14.20M | Q2 2026 | Aug 14, 2026 |
| Summittx Capital, L.P. | Buy | +597,453 | — | 597,453 | $2.89M | Q2 2026 | Aug 14, 2026 |
| Balyasny Asset Management L.P. | Buy | +556,027 | — | 556,027 | $2.69M | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +537,064 | — | 537,064 | $2.60M | Q2 2026 | Aug 14, 2026 |
| Woodline Partners Lp | Sell | -533,866 | -53.7% | 459,805 | $2.23M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Sell | -247,899 | -63.0% | 145,803 | $705.69K | Q2 2026 | Aug 14, 2026 |
| Sio Capital Management, Llc | Sell | -127,267 | -19.4% | 529,933 | $2.56M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Buy | +96,190 | +4.3% | 2,318,692 | $11.22M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Buy | +87,933 | — | 87,933 | $425.60K | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +64,220 | — | 64,220 | $310.82K | Q2 2026 | Aug 14, 2026 |
| Adar1 Capital Management, Llc | Buy | +44,947 | +324.3% | 58,808 | $284.63K | Q2 2026 | Aug 14, 2026 |
| Prosight Management, Lp | Sell | -41,116 | -8.0% | 474,638 | $2.30M | Q2 2026 | Aug 14, 2026 |
| Velan Capital Investment Management Lp | Buy | +40,000 | — | 40,000 | $193.60K | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Buy | +22,389 | — | 22,389 | $108.36K | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +22,022 | — | 22,022 | $107.00K | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +15,913 | — | 15,913 | $77.02K | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +13,839 | — | 13,839 | $66.98K | Q2 2026 | Aug 14, 2026 |
| Mirae Asset Global Etfs Holdings Ltd. | Buy | +12,186 | — | 12,186 | $58.98K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +5,091 | +1272.8% | 5,491 | $26.58K | Q2 2026 | Aug 14, 2026 |
| Legal & General Group Plc | Buy | +2,576 | — | 2,576 | $12.43K | Q2 2026 | Aug 14, 2026 |
| Royal Bank Of Canada | Buy | +938 | — | 938 | $5.00K | Q2 2026 | Aug 14, 2026 |
| Vanguard Capital Management Llc | Buy | +227,627 | +22.5% | 1,238,705 | $6.00M | Q2 2026 | Aug 13, 2026 |
| Morgan Stanley | Sell | -184,808 | -78.9% | 49,379 | $239.00K | Q2 2026 | Aug 13, 2026 |
| Vanguard Portfolio Management Llc | Buy | +179,594 | — | 179,594 | $869.24K | Q2 2026 | Aug 13, 2026 |
| Northern Trust Corp | Buy | +171,725 | +397.5% | 214,921 | $1.04M | Q2 2026 | Aug 13, 2026 |
Frequently asked questions about ANTX activity
Which institutional owners are buying ANTX?
Institutional owners buying ANTX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in ANTX activity?
"Buy" means an investor increased their reported position in ANTX compared to the prior reporting period. This reflects growing exposure to AN2 THERAPEUTICS INC (ANTX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in ANTX increasing?
Institutional interest in ANTX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related ANTX Institutional Insights
- ANTX Overview
- ANTX 13F Institutional Holders
- ANTX Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ANTX Insider Trading & SEC Form 4 Activity
- ANTX Articles
- Top Institutional Investor Stock Rankings